While S100A proteins were not required for AML initiation in the HoxA9-Meis1 mouse model of AML, treatment with an anti-S100A8 antibody induced AML cell differentiation in vivo and impaired AML progression. This evidence concerns the gene MEIS1 and acute myeloid leukemia.